AZN logo

AstraZeneca (AZN)

Profile

Full Name

AstraZeneca PLC

Ticker Symbol

AZN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United Kingdom

IPO

May 12, 1993

Indexes

NASDAQ 100

Website

http://www.astrazeneca.com

Employees

94300

Key Details

Price

$66.29(+2.19%)

Market cap

$205.52B(Mega cap)

Last Dividend

$1.05

TTM Dividend yield

2.34%

Annual revenue

$54.07B(+18.03% YoY)

Annual EPS

$2.25(+18.11% YoY)

PE ratio

29.40

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$66.29
AZN price is $66.29

30-Day Relative Volume

0.89
AZN 30-day relative volume is 0.89

Price Performance

Price Most recent change

+2.19%
AZN price was up +2.19% on Apr 11, 2025

Price YTD change

+1.18%
AZN price is up +1.18% since January 1st

Price 1-year change

-4.55%
AZN price is down -4.55% year-on-year

Price 3-year change

-6.14%
AZN price is down -6.14% over the past 3 years

Price Range

Price All-time high

$87.68
AZN price is currently -24.40% below its historical high of $87.68

Price 3-year low

$52.65
AZN price is currently +25.91% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$205.52B
AZN market capitalization is $205.52 billion

Market cap 3-year change

-6.1%
AZN market capitalization is down -6.1% over the past 3 years

Market cap All-time high

$272.85B
AZN market capitalization is currently -24.68% below its historical high of $272.85 billion

Market cap sector rank

99.42%
AZN market capitalization is higher than 99.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
AZN {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+0.05%
AZN shares outstanding is up +0.05% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.31
AZN beta is 0.31

200-day SMA

$74.19
AZN price is currently -10.64% below its 200-day simple moving average

50-day SMA

$73.44
AZN price is currently -9.73% below its 50-day simple moving average

RSI

35.03
AZN 14-day relative strength index is 35.03

Volume

0.89
AZN 30-day relative volume is 0.89

ATR

$2.47
AZN average true range is $2.47

10-day Historical Volatility

50.13%
AZN 10-day historical volatility is 50.13%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.05
AZN last dividend was $1.05 per share, with an ex-dividend date of February 21, 2025

Next Dividend

-
AZN next dividend has not yet been announced

Dividend per share

Dividend per share

$1.49
AZN annual dividend per share is $1.49

Dividend per share Sector Rank

58.14%
AZN annual dividend per share is higher than 58.14% of companies in Healthcare sector

Dividend per share 1-Year Change

+2.41%
AZN annual dividend per share is up +2.41% year-on-year

Dividend per share 3-Year Change

+6.07%
AZN annual dividend per share is up +6.07% over the past 3 years

Dividend yield

Dividend yield

2.24%
AZN annual dividend yield is 2.24%

Dividend yield Sector Rank

50.59%
AZN annual dividend yield is higher than 50.59% of companies in Healthcare sector

Other

Payout ratio

65.80%
AZN annual payout ratio is 65.80%

Dividends paid

$4.63B
AZN annual dividends paid is $4.63 billion

Free cash flow

$7.28B
AZN annual free cash flow is $7.28 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$54.07B
AZN annual revenue is $54.07 billion

Revenue Analysts estimate

$57.37B
AZN annual revenue is currently -5.75% lower than the consensus analysts' forecast

Revenue 1-year change

+18.03%
AZN annual revenue is up +18.03% year-on-year

Revenue Sector rank

98.32%
AZN annual revenue is higher than 98.32% of companies in Healthcare sector

EPS

EPS

$2.25
AZN annual earnings per share is $2.25

EPS Analysts estimate

$4.48
AZN annual earnings per share is currently -49.77% lower than the consensus analysts' forecast

EPS 1-year change

+18.11%
AZN annual earnings per share is up +18.11% year-on-year

EPS Sector rank

92.73%
AZN annual earnings per share is higher than 92.73% of companies in Healthcare sector

Profit

Gross profit

$43.87B
AZN annual gross profit is $43.87 billion

Gross margin

81.12%
AZN annual gross profit margin is 81.12%

Operating profit

$10.00B
AZN annual operating income is $10.00 billion

Operating margin

18.50%
AZN annual operating profit margin is 18.50%

Net income

$7.04B
AZN annual net profit is $7.04 billion

Net margin

13.01%
AZN annual net profit margin is 13.01%

Expenses

Total expenses

$44.07B
AZN annual total expenses is $44.07 billion

Operating expenses

$33.86B
AZN annual total operating expenses is $33.86 billion

Cost of goods sold

$10.21B
AZN annual cost of goods sold is $10.21 billion

Selling, general & administrative expenses

$20.53B
AZN annual SGA is $20.53 billion

Depreciation and amortization

$6.69B
AZN annual depreciation & amortization is $6.69 billion

Interest expense

$1.68B
AZN annual interest expense is $1.68 billion

Income tax

$1.65B
AZN annual income tax is $1.65 billion

EBIT & EBITDA

EBIT

$10.43B
AZN annual earnings before interest & taxes is $10.43 billion

EBITDA

$17.12B
AZN annual EBITDA is $17.12 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$104.03B
AZN annual total assets is $104.03 billion

Non current assets

$78.21B
AZN annual long term assets is $78.21 billion

Current assets

$25.83B
AZN annual total current assets is $25.83 billion

Cash and cash equivalents

$5.49B
AZN annual cash & cash equivalents is $5.49 billion

Accounts receivable

$8.30B
AZN annual accounts receivable is $8.30 billion

Inventory

$5.29B
AZN annual inventory is $5.29 billion

Liabilities

Total liabilities

$63.16B
AZN annual total liabilities is $63.16 billion

Long term liabilities

$35.30B
AZN annual total long term liabilities is $35.30 billion

Current liabilities

$27.87B
AZN annual total current liabilities is $27.87 billion

Accounts payable

$3.64B
AZN annual accounts payable is $3.64 billion

Debt

Total debt

$30.30B
AZN annual total debt is $30.30 billion

Total debt 1-year change

+5.85%
AZN annual total debt is up +5.85% year-on-year

Long term debt

$27.62B
AZN annual long term debt is $27.62 billion

Short term debt

$2.68B
AZN annual short term debt is $2.68 billion

Equity & Capital

Shareholders equity

$40.79B
AZN annual stockholders equity is $40.79 billion

Book value

$40.79B
AZN annual book value is $40.79 billion

Retained earnings

$3.16B
AZN annual retained earnings is $3.16 billion

Working capital

-$2.04B
AZN annual working capital is -$2.04 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$11.86B
AZN annual cash flow from operations is $11.86 billion

Cash from operations 1-year change

+14.65%
AZN annual cash flow from operations is up +14.65% year-on-year

Cash from investing

-$7.98B
AZN annual cash flow from investing activities is -$7.98 billion

Cash from investing 1-year change

-96.36%
AZN annual cash flow from investing activities is down -96.36% year-on-year

Cash from financing

-$4.00B
AZN annual cash flow from financing activities is -$4.00 billion

Cash from financing 1-year change

+39.15%
AZN annual cash flow from financing activities is up +39.15% year-on-year

CAPEX

CAPEX

$4.59B
AZN annual capital expenditures is $4.59 billion

CAPEX 1-year change

+21.39%
AZN annual capital expenditures is up +21.39% year-on-year

Free Cash Flow

Free cash flow

$7.28B
AZN annual free cash flow is $7.28 billion

Free cash flow 1-year change

+10.78%
AZN annual free cash flow is up +10.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

81.12%
AZN annual gross profit margin is 81.12%

Operating margin

18.50%
AZN annual operating profit margin is 18.50%

Net margin

13.01%
AZN annual net profit margin is 13.01%

ROA & ROE

ROA

6.86%
AZN annual return on assets is 6.86%

ROE

17.58%
AZN annual return on equity is 17.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

29.40
AZN price to earnings ratio is 29.40

PE ratio Sector rank

59.31%
AZN price to earnings ratio is higher than 59.31% of companies in Healthcare sector

PB Ratio

PB ratio

-
AZN price to book ratio value is unknown

PB ratio Sector rank

-
AZN price to book ratio is unknown

PS Ratio

PS ratio

3.80
AZN price to sales ratio is 3.80

PS ratio Sector rank

59.87%
AZN price to sales ratio is higher than 59.87% of companies in Healthcare sector

Enterprise value

Enterprise value

-
AZN enterprise value value is unknown

Enterprise value Sector rank

-
AZN enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
AZN EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
AZN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.93
AZN annual current ratio is 0.93

Quick ratio

0.74
AZN annual quick ratio is 0.74

Leverage

Debt to equity

0.71
AZN annual debt to equity ratio is 0.71

Interest coverage ratio

6.20
AZN annual interest coverage ratio is 6.20

Risk & Stability

Piotroski F-Score

-
AZN piotroski f-score value is unknown

Altman Z-Score

2.82
AZN altman z-score is 2.82

Analyst ratings

Recent major analysts updates

Feb 13, 25 UBS
Buy
Nov 20, 24 UBS
Neutral
Sep 11, 24 Erste Group
Buy
Aug 12, 24 TD Cowen
Buy
May 30, 24 Goldman Sachs
Buy
May 30, 24 Argus Research
Buy
Apr 26, 24 BMO Capital
Outperform
Apr 16, 24 Deutsche Bank
Hold
Feb 12, 24 BMO Capital
Outperform
Feb 8, 24 Deutsche Bank
Hold

Institutional Ownership

Similar stocks

MRK logo
Merck & Co (MRK)
NVS logo
Novartis AG (NVS)
ABT logo
Abbott Laboratories (ABT)
ISRG logo
Intuitive Surgical (ISRG)
TMO logo
Thermo Fisher Scientific (TMO)
AMGN logo
Amgen (AMGN)
BSX logo
Boston Scientific (BSX)
DHR logo
Danaher (DHR)
SYK logo
Stryker (SYK)
  • What is the ticker symbol for AstraZeneca?
  • Does AstraZeneca pay dividends?
  • What sector is AstraZeneca in?
  • What industry is AstraZeneca in?
  • What country is AstraZeneca based in?
  • When did AstraZeneca go public?
  • Is AstraZeneca in the S&P 500?
  • Is AstraZeneca in the NASDAQ 100?
  • Is AstraZeneca in the Dow Jones?
  • When was AstraZeneca's last earnings report?
  • When does AstraZeneca report earnings?
  • Should I buy AstraZeneca stock now?

What is the ticker symbol for AstraZeneca?

The ticker symbol for AstraZeneca is NASDAQ:AZN

Does AstraZeneca pay dividends?

Yes, AstraZeneca pays dividends. The last payment was $1.05, with an ex-dividend date on February 21, 2025

What sector is AstraZeneca in?

AstraZeneca is in the Healthcare sector

What industry is AstraZeneca in?

AstraZeneca is in the Drug Manufacturers - General industry

What country is AstraZeneca based in?

AstraZeneca is headquartered in United Kingdom

When did AstraZeneca go public?

AstraZeneca's initial public offering (IPO) was on May 12, 1993

Is AstraZeneca in the S&P 500?

No, AstraZeneca is not included in the S&P 500 index

Is AstraZeneca in the NASDAQ 100?

Yes, AstraZeneca is included in the NASDAQ 100 index

Is AstraZeneca in the Dow Jones?

No, AstraZeneca is not included in the Dow Jones index

When was AstraZeneca's last earnings report?

AstraZeneca's most recent earnings report was on Feb 6, 2025

When does AstraZeneca report earnings?

The next expected earnings date for AstraZeneca is Apr 29, 2025

Should I buy AstraZeneca stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page